Latest Breaking News On - American college of rheumatology convergence - Page 6 : comparemela.com

Horizon Therapeutics (HZNP) Announces Sustained Patient Response to KRYSTEXXA Injection with Methotrexate Compared to KRYSTEXXA Alone

Lupus Foundation of America Research Initiatives to be Presented at the 2022 American College of Rheumatology Annual Meeting

/PRNewswire/ The American College of Rheumatology Convergence 2022 meeting will be held in Philadelphia, PA from November 10-14, 2022. The Lupus Foundation.

Horizon Therapeutics plc: Sustained Patient Response to KRYSTEXXA (pegloticase) Injection with Methotrexate Compared to KRYSTEXXA Alone Shown through Month 12 in MIRROR Randomized Controlled Trial

Month 12 results from MIRROR randomized controlled trial to be featured on Nov. 13, 11:45 a.m. EST during plenary session at the American College of Rheumatology Convergence 2022 Imaging

Aurinia Reports Third Quarter and Nine Months 2022 Financial and Operational Results

03.11.2022 - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for the three months ended September 30, 2022. Amounts, unless specified otherwise, are expressed in U.S. dollars. Total net revenue was $55.8 .

ProDERM Study Results of octagam® 10% Treatment in Patients With Dermatomyositis Published in the New England Journal of Medicine